Clinical Trial

Axtria Launches LUCCID to Transform Clinical Data Management with GenAI

Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --…

8 months ago

Axtria Launches LUCCID to Transform Clinical Data Management with GenAI

Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --…

8 months ago

Axtria Launches LUCCID to Transform Clinical Data Management with GenAI

Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --…

8 months ago

ProofPilot Announces Strategic Partnership with the Digital Medicine Society to Advance Digital Health in Clinical Trials

NEW YORK, April 29, 2025 /PRNewswire/ -- ProofPilot, the industry's first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and…

8 months ago

ProofPilot Announces Strategic Partnership with the Digital Medicine Society to Advance Digital Health in Clinical Trials

NEW YORK, April 29, 2025 /PRNewswire/ -- ProofPilot, the industry's first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and…

8 months ago

Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology

LAS VEGAS, April 29, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner,…

8 months ago

Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on…

8 months ago

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025…

8 months ago

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025…

8 months ago

Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting

Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer…

8 months ago